Advancing patient-derived regenerative medicine
Tissue Engineering Innovations
Solutions To Global Problems
Macular degeneration is a leading cause of vision loss in Americans 60 years of age and older. As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. The number of people living with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040.
Estimates of the global cost of visual impairment due to age-related macular degeneration is $343 billion, including $255 billion in direct health care costs.
196
Million People
The number of people living with macular degeneration is expected to reach 196 million worldwide by 2020 and increase to 288 million by 2040.
661,000Americans
The number of Americans that have kidney failure. Of these, 468,000 individuals are on dialysis, and roughly 193,000 live with a functioning kidney transplant.
$343Billion
The estimated global cost of visual impairment due to age-related macular degeneration is $343 billion, including $255 billion in direct health care costs.
Macular Degeneration Cure
Macular degeneration remains incurable. Existing therapies slow
decline but do not restore vision.
Mesogen Will Solve This Crisis
The Mesogen Diabetes Solution: Personalized Cell Therapy
Diabetes remains a chronic, progressive disease. Current therapies
manage blood glucose but do not restore endogenous insulin production or
reverse beta-cell loss. Long-term disease management often requires lifelong
pharmacologic intervention and ongoing monitoring, with cumulative risk of
complications over time.
The Mesogen Solution
About Mesogen
Mesogen will be a provider of autologous engineered Retinal Pigment Epithelium (RPE) cell patches for transplant. This will be a curative treatment. Headquartered in the Woodlands, Texas, in the United States, the company will focus on solving some of the largest problems facing humanity through advanced tissue engineering innovations.
